The objective of the study was to clinically evaluate the safety and effectiveness of a new multi-purpose disinfecting solution in patients wearing silicone hydrogel soft contact lenses.

• Successful daily wear of Night & Day® or Acuvue® Advance™ silicone hydrogel contact for at least two weeks.
• Use of AOSEPT® ClearCare™ only as the pre-study care regimen for at least two weeks (rewetting drops use is also acceptable).
• Successful lens wear for at least 8 hours per day.
• Vision correctable to 20/30.
• Normal eyes - no current ocular abnormalities that prevent successful contact lens wear.
• No corneal surgery within the past 12 months.
• No systemic disease that affects that eye or that could be worsened by the use of contact lenses or solutions.
• No over-the-counter or prescription ocular medication.
• No enrollment in another clinical study within 30 days prior to enrollment.